1. Home
  2. GFAI vs QNCX Comparison

GFAI vs QNCX Comparison

Compare GFAI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

N/A

Current Price

$0.35

Market Cap

15.9M

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$31.26

Market Cap

17.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFAI
QNCX
Founded
2018
2012
Country
Singapore
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
17.5M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
GFAI
QNCX
Price
$0.35
$31.26
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$4.50
N/A
AVG Volume (30 Days)
152.7K
33.9K
Earning Date
04-21-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
$14.12
N/A
Revenue Next Year
$10.25
N/A
P/E Ratio
N/A
$11.36
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.08
52 Week High
$1.38
$33.11

Technical Indicators

Market Signals
Indicator
GFAI
QNCX
Relative Strength Index (RSI) 46.71 91.24
Support Level $0.31 $0.89
Resistance Level $0.42 N/A
Average True Range (ATR) 0.03 2.25
MACD 0.01 0.56
Stochastic Oscillator 62.33 94.72

Price Performance

Historical Comparison
GFAI
QNCX

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: